| Title: | Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening |
| Journal: | Atherosclerosis |
| Published: | 22 Mar 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40174266/ |
| DOI: | https://doi.org/10.1016/j.atherosclerosis.2025.119174 |
Publication 16235
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND AND AIMS: An elevated level of lipoprotein(a), or Lp(a), in the bloodstream has been causally linked to the development of atherosclerotic cardiovascular disease and calcific aortic valve stenosis. Steady state levels of circulating lipoproteins are modulated by their rate of clearance, but the identity of the Lp(a) uptake receptor(s) has been controversial.</p>
METHODS: We performed a genome-scale CRISPR screen to functionally interrogate all potential Lp(a) uptake regulators in HuH7 cells. Screen validation was performed by single gene disruption and overexpression. Direct binding between purified lipoproteins and recombinant protein was tested using biolayer interferometry. An association between human genetic variants and circulating Lp(a) levels was analyzed in the UK Biobank cohort.</p>
RESULTS: The top positive and negative regulators of Lp(a) uptake in our screen were LDLR and MYLIP, encoding the LDL receptor and its ubiquitin ligase IDOL, respectively. We also found a significant correlation for other genes with established roles in LDLR regulation. No other gene products, including those previously proposed as Lp(a) receptors, exhibited a significant effect on Lp(a) uptake in our screen. We validated the functional influence of LDLR expression on HuH7 Lp(a) uptake, confirmed in vitro binding between the LDLR extracellular domain and purified Lp(a), and detected an association between loss-of-function LDLR variants and increased circulating Lp(a) levels in the UK Biobank cohort.</p>
CONCLUSIONS: Our findings support a central role for the LDL receptor in mediating Lp(a) uptake by hepatocytes.</p>
10 Authors
- Taslima G Khan
- Juliana Bragazzi Cunha
- Chinmay Raut
- Michael Burroughs
- Hitarthi S Vyas
- Kyle Leix
- Sascha N Goonewardena
- Alan V Smrcka
- Elizabeth K Speliotes
- Brian T Emmer
1 Application
| Application ID | Title |
|---|---|
| 18120 | Identifying causes of obesity and liver disease using population genetics |
Enabling scientific discoveries that improve human health